Recent changes
Track the most recent changes to the wiki on this page.
17 October 2017
| m 00:41 | Allogeneic HSCT (diff | hist) . . (0) . . AricHallMD (talk | contribs) (→Busulfan & Fludarabine {{#subobject:576283|Regimen=1}}) |
16 October 2017
| m 22:03 | Gemtuzumab ozogamicin (Mylotarg) (diff | hist) . . (-1) . . Warner-admin (talk | contribs) (Text replacement - "Association.. " to "Association. ") |
| m 22:03 | Anaplastic glioma (diff | hist) . . (-2) . . Warner-admin (talk | contribs) (Text replacement - "Society.. " to "Society. ") |
| m 22:03 | Breast cancer (diff | hist) . . (-1) . . Warner-admin (talk | contribs) (Text replacement - "Group.." to "Group.") |
| m 22:03 | Bladder cancer (diff | hist) . . (-2) . . Warner-admin (talk | contribs) (Text replacement - "Group.." to "Group.") |
| m 22:03 | Multiple myeloma - obsolete (diff | hist) . . (-1) . . Warner-admin (talk | contribs) (Text replacement - "group.." to "group.") |
| m 22:02 | CNS lymphoma (diff | hist) . . (-4) . . Warner-admin (talk | contribs) (Text replacement - "‘’" to "''") |
| m 22:00 | Diffuse large B-cell lymphoma (diff | hist) . . (-8) . . Warner-admin (talk | contribs) (→R-CHOP {{#subobject:240cc2|Regimen=1}}) |
| 21:41 | Levels of Evidence (diff | hist) . . (+1,123) . . PeterYang (talk | contribs) |
| 21:18 | User:AricHallMD (diff | hist) . . (+116) . . PeterYang (talk | contribs) |
| m 11:47 | Multiple myeloma (5 changes | history) . . (+2) . . [Jwarner (5×)] | |
| m | 11:47 (cur | prev) . . (+1) . . Jwarner (talk | contribs) (→Regimen {{#subobject:5ad72e|Variant=1}}) | |
| m | 11:46 (cur | prev) . . (0) . . Jwarner (talk | contribs) (→Regimen #1, Len @ 25 mg 21/28 {{#subobject:107197|Variant=1}}) | |
| m | 11:44 (cur | prev) . . (-1) . . Jwarner (talk | contribs) (→Regimen {{#subobject:PYV3|Variant=1}}) | |
| m | 11:43 (cur | prev) . . (+1) . . Jwarner (talk | contribs) (→Regimen {{#subobject:PYV3|Variant=1}}) | |
| m | 11:38 (cur | prev) . . (+1) . . Jwarner (talk | contribs) (→Regimen #4, 21-day cycles, response-adapted {{#subobject:47b011|Variant=1}}) |
| m 11:25 | Chronic lymphocytic leukemia (CLL/SLL) (diff | hist) . . (-2,094) . . Jwarner (talk | contribs) |
15 October 2017
| 22:33 | Allogeneic HSCT (4 changes | history) . . (+1,251) . . [AricHallMD (4×)] | |
| 22:33 (cur | prev) . . (+5) . . AricHallMD (talk | contribs) | ||
| m | 22:29 (cur | prev) . . (+16) . . AricHallMD (talk | contribs) (→Busulfan & Fludarabine ) (Tag: Visual edit) | |
| m | 15:30 (cur | prev) . . (+75) . . AricHallMD (talk | contribs) (Tag: Visual edit) | |
| 15:29 (cur | prev) . . (+1,155) . . AricHallMD (talk | contribs) (Put Rambaldi Flu / Bu First) (Tag: Visual edit: Switched) |
| N 22:23 | Aric's Test Page (6 changes | history) . . (+7,470) . . [AricHallMD (6×)] | |
| 22:23 (cur | prev) . . (+90) . . AricHallMD (talk | contribs) (Still editing) (Tag: Visual edit) | ||
| 22:12 (cur | prev) . . (+761) . . AricHallMD (talk | contribs) (Haven't finished fixing up regimen 2 yet) (Tag: Visual edit) | ||
| 21:54 (cur | prev) . . (+491) . . AricHallMD (talk | contribs) (→Busulfan & Fludarabine {{#subobject:576283|Regimen=1}}) | ||
| m | 21:52 (cur | prev) . . (+237) . . AricHallMD (talk | contribs) (→Busulfan & Fludarabine ) (Tag: Visual edit) | |
| 15:36 (cur | prev) . . (+64) . . AricHallMD (talk | contribs) (trying to work on this) (Tag: Visual edit) | ||
| N | 15:33 (cur | prev) . . (+5,827) . . AricHallMD (talk | contribs) (Created page with "==Busulfan & Fludarabine {{#subobject:576283|Regimen=1}}== {| class="wikitable" style="float:right; margin-left: 5px;" |- |back to top |} BuFlu: '''<u>Bu</u>'''sulfan...") |
| m 15:57 | Gastric cancer (diff | hist) . . (-19) . . Warner-admin (talk | contribs) |
| 15:16 | User:AricHallMD (diff | hist) . . (-6) . . AricHallMD (talk | contribs) (I updated my credentials.) (Tag: Visual edit) |
14 October 2017
| 23:13 | Multiple myeloma - obsolete (diff | hist) . . (+72) . . Warner-admin (talk | contribs) (→References) |
| 23:11 | Follicular lymphoma - obsolete (diff | hist) . . (+68) . . Warner-admin (talk | contribs) (→References) |
| 23:11 | Hodgkin lymphoma - obsolete (diff | hist) . . (+70) . . Warner-admin (talk | contribs) (→References) |
| m 23:10 | Diffuse large B-cell lymphoma - obsolete (diff | hist) . . (+70) . . Warner-admin (talk | contribs) (→References) |
| m 19:58 | Acute myeloid leukemia (diff | hist) . . (0) . . Warner-admin (talk | contribs) (→FLAG-IDA {{#subobject:d8c75b|Regimen=1}}) |
| 19:54 | (Move log) . . [Warner-admin (3×)] | |
| 19:54 . . Warner-admin (talk | contribs) moved page Category:Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL) medications to Category:Chronic lymphocytic leukemia (CLL/SLL) medications without leaving a redirect | ||
| 17:00 . . Warner-admin (talk | contribs) moved page Category:Cancer of unknown primary regimens to Category:Adenocarcinoma of unknown primary regimens without leaving a redirect | ||
| 16:56 . . Warner-admin (talk | contribs) moved page Unknown primary to Adenocarcinoma of unknown primary (Breaking apart into multiple pages) |
| m 19:53 | Sirolimus (Rapamune) (diff | hist) . . (+1) . . Warner-admin (talk | contribs) (Text replacement - "Category:Autoimmune cytopenia medications" to "Category:Autoimmune cytopenias medications") |
| m 19:52 | Alemtuzumab (Campath) (diff | hist) . . (+1) . . Warner-admin (talk | contribs) (Text replacement - "Category:Autoimmune cytopenia medications" to "Category:Autoimmune cytopenias medications") |
| 17:21 | (Upload log) . . PeterYang (talk | contribs) uploaded a new version of File:Ipilimumab.pdf (Ipilimumab (Yervoy) package insert (locally hosted backup). Original source: http://packageinserts.bms.com/pi/pi_yervoy.pdf, accessed 10/14/2017.) |
| N 17:19 | Ipilimumab in all diseases (diff | hist) . . (+666) . . PeterYang (talk | contribs) (Created page with "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' Is t...") |
| 17:18 | Melanoma (diff | hist) . . (-2,692) . . PeterYang (talk | contribs) (→Ipilimumab monotherapy {{#subobject:89bbc6|Regimen=1}}) |
| N 17:17 | Ipilimumab (Yervoy) for melanoma, adjuvant (2 changes | history) . . (+4,909) . . [PeterYang (2×)] | |
| m | 17:17 (cur | prev) . . (+76) . . PeterYang (talk | contribs) | |
| N | 17:03 (cur | prev) . . (+4,833) . . PeterYang (talk | contribs) (Created page with "<includeonly>Source: Ipilimumab (Yervoy) for melanoma, adjuvant {| class="wikitable" style="float:right; margin-left: 5px;" |- |back to top |}</includeonly> <noin...") |
| N 17:03 | Category:SCC of unknown primary regimens (diff | hist) . . (+35) . . Warner-admin (talk | contribs) (Created page with "Category:Site-agnostic regimens") |
| N 17:03 | SCC of unknown primary (diff | hist) . . (+4,946) . . Warner-admin (talk | contribs) (Created page with "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' Is th...") |
| m 17:02 | Nivolumab (Opdivo) for melanoma, adjuvant (diff | hist) . . (+58) . . PeterYang (talk | contribs) |
| N 16:59 | Category:NET of unknown primary regimens (diff | hist) . . (+35) . . Warner-admin (talk | contribs) (Created page with "Category:Site-agnostic regimens") |
| N 16:59 | NET of unknown primary (diff | hist) . . (+1,787) . . Warner-admin (talk | contribs) (Created page with "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' Is th...") |
| 16:58 | Main Page (diff | hist) . . (+180) . . Warner-admin (talk | contribs) (→Links to Main Disease Pages) |
| 16:56 | Unknown primary (diff | hist) . . (-3,514) . . Warner-admin (talk | contribs) |
